Biosimilars are new versions of generic pharmaceuticals, introduced in the market following the patent expiry of the latter. Biosimilars may act differently from their predecessors due to differences in molecular structures and preparation methods. The biosimilars market is expected to have a decent growth rate due to the imminent patent expiry of many blockbuster drugs. We track the markets for the major biosimilars drug types, their ingredients, applications, and technologies.   see less

Biosimilars are new versions of generic pharmaceuticals, introduced in the market following the patent expiry of the latter. Biosimilars may act differently from their predecessors due to differences in molecular structures and preparation methods. T ....see more